TRUALT Share Price | TruAlt Bioenergy Ltd Stock Analysis & Recommendation

Q: Are TruAlt Bioenergy Ltd latest results good or bad?

TruAlt Bioenergy Ltd's latest results present a mixed picture. On one hand, the company achieved a remarkable quarter-on-quarter revenue growth of 520.96%, reaching ₹713.24 crores, and returned to profitability with a net profit of ₹69.33 crores, marking a significant increase of 282.74% compared to the previous quarter. This indicates strong operational momentum and recovery in demand.However, the profitability metrics reveal concerning trends. The operating margin has compressed significantly from 30.01% in the same quarter last year to 18.79% this year, and the profit after tax (PAT) margin has also declined from 18.11% to 9.70%. This suggests that while the company is generating more revenue, it is struggling to maintain profitability due to rising costs or operational inefficiencies.Additionally, the year-on-year comparison shows a decline in net profit by 7.79%, which raises concerns about the sustainability of the recent growth. The company's elevated debt levels and weak interest coverage ratio further complicate its financial health.In summary, while the revenue growth is impressive and indicates a recovery, the significant margin compression and declining profitability metrics suggest that the results are not entirely favorable. Investors should be cautious and monitor how the company addresses these challenges moving forward.

Q: Should I buy, sell or hold TruAlt Bioenergy Ltd?

Based on the current situation of TruAlt Bioenergy Ltd, it would be advisable to consider selling your shares. The company is burdened with high debt, reflected in a debt-to-equity ratio of 0, and has been reporting losses, which has resulted in a negative return on capital employed (ROCE). Additionally, the company's profit after tax has significantly declined by 44.47% over the last six months.Moreover, there is a concerning trend of decreasing participation from institutional investors, who have reduced their stake by 0.9% in the last quarter. Institutional investors typically have more resources and expertise to evaluate a company's fundamentals, so their reduced interest could be a red flag.While the company does have an attractive valuation with a ROCE of 8.9 and a favorable enterprise value to capital employed ratio of 1.8, these factors may not outweigh the negative indicators. Given the flat performance of the stock over the past year and the significant drop in profits, it may be prudent to sell rather than hold or buy more shares at this time.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.62 lacs (-57.19%) Volume

Shareholding (Mar 2026)

FII

0.66%

Held by 11 FIIs

DII

2.32%

Held by 9 DIIs

Promoter

70.55%

Are TruAlt Bioenergy Ltd latest results good or bad?

04-Feb-2026

TruAlt Bioenergy Ltd's latest results show impressive revenue growth of 520.96% and a return to profitability, but declining operating and profit margins, along with a year-on-year net profit drop of 7.79%, raise concerns about sustainability. Investors should be cautious due to these mixed signals and the company's elevated debt levels.

View full answer

Should I buy, sell or hold TruAlt Bioenergy Ltd?

31-Mar-2026

Which are the latest news on TruAlt Bioenergy?

23-Apr-2026

TruAlt Bioenergy Ltd Surges 7.16% to Day's High of Rs 493.4 — Outperforms Sector by 6.05 Percentage Points
TruAlt Bioenergy Ltd is Rated Sell by MarketsMOJO

Why is TruAlt Bioenergy Ltd falling/rising?

24-Apr-2026

As of 23-Apr, TruAlt Bioenergy Ltd's stock price is rising, currently at 489.15, reflecting a 6.39% increase. The stock has outperformed the Sensex and shows strong recent performance metrics, although there are concerns about declining investor participation and financial fundamentals.

View full answer

Compare TruAlt Bioenergy with Similar Stocks

GHCL Chemplast Sanmar Tanfac Inds.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Debt company with Weak Long Term Fundamental Strength

The company is Net-Debt Free
The company has reported losses. Due to this company has reported negative ROCE

Flat results in Dec 25

36.85% of Promoter Shares are Pledged

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Commodity Chemicals

Market cap

INR 4,108 Cr (Small Cap)

P/E

28.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.89

Return on Equity

10.11%

Price to Book

3.02

Revenue and Profits:

Net Sales:

713 Cr

(Quarterly Results - Dec 2025)

Net Profit:

69 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

49.66%

6 Months

4.64%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

TruAlt Bioenergy for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

TruAlt Bioenergy Ltd Valuation Shifts to Fair Amid Strong Price Gains

TruAlt Bioenergy Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating as of late March 2026. This change reflects evolving market perceptions amid rising price-to-earnings and price-to-book value ratios, positioning the company differently within the commodity chemicals sector and against its peers.

Read full news article

TruAlt Bioenergy Ltd Surges 7.16% to Day's High of Rs 493.4 — Outperforms Sector by 6.05 Percentage Points

The Sensex declined by 0.53% on 23 Apr 2026, while TruAlt Bioenergy Ltd surged 7.16%, marking a 6.05 percentage-point outperformance over its Commodity Chemicals sector. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which has now extended its winning streak to two consecutive days.

Read full news article

TruAlt Bioenergy Ltd is Rated Sell by MarketsMOJO

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

14-Apr-2026 | Source : BSE

Please find attached certificate.

Disclosure Under Regulation 30(5) Of SEBI (LODR) Regulation 2015

30-Mar-2026 | Source : BSE

Please find attached intimation.

Closure of Trading Window

27-Mar-2026 | Source : BSE

Please find attached intimation regarding closure of Trading window.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

1.28

Debt to EBITDA (avg)

5.14

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.64

Tax Ratio

7.58%

Dividend Payout Ratio

Pledged Shares

36.85%

Institutional Holding

10.07%

ROCE (avg)

8.87%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.02

EV to EBIT

23.35

EV to EBITDA

18.27

EV to Capital Employed

2.07

EV to Sales

2.89

PEG Ratio

Dividend Yield

ROCE (Latest)

8.87%

ROE (Latest)

10.11%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

36.8532

Mutual Funds

Held by 5 Schemes (6.7%)

FIIs

Held by 11 FIIs (0.66%)

Promoter with highest holding

Vijaykumar Nirani (17.88%)

Highest Public shareholder

Rakeshkumar Viththalbhai Patel (3.82%)

Individual Investors Holdings

13.5%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "703.02",
          "val2": "104.48",
          "chgp": "572.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "129.05",
          "val2": "-11.79",
          "chgp": "1,194.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "39.65",
          "val2": "38.01",
          "chgp": "4.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "66.02",
          "val2": "-42.75",
          "chgp": "254.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.36%",
          "val2": "-11.28%",
          "chgp": "29.64%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398.41",
          "val2": "573.53",
          "chgp": "-30.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.10",
          "val2": "27.23",
          "chgp": "-15.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.26",
          "val2": "67.15",
          "chgp": "12.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-42.72",
          "val2": "-41.99",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.80%",
          "val2": "4.75%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,101.43",
          "val2": "980.84",
          "chgp": "12.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "152.15",
          "val2": "146.27",
          "chgp": "4.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "114.91",
          "val2": "102.57",
          "chgp": "12.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "23.30",
          "val2": "30.39",
          "chgp": "-23.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.81%",
          "val2": "14.91%",
          "chgp": "-1.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,880.12",
          "val2": "1,223.40",
          "chgp": "53.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "297.20",
          "val2": "188.08",
          "chgp": "58.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "141.04",
          "val2": "143.08",
          "chgp": "-1.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "140.62",
          "val2": "31.81",
          "chgp": "342.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.81%",
          "val2": "15.37%",
          "chgp": "0.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

703.02

104.48

572.88%

Operating Profit (PBDIT) excl Other Income

129.05

-11.79

1,194.57%

Interest

39.65

38.01

4.31%

Exceptional Items

0.00

Standalone Net Profit

66.02

-42.75

254.43%

Operating Profit Margin (Excl OI)

18.36%

-11.28%

29.64%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

398.41

573.53

-30.53%

Operating Profit (PBDIT) excl Other Income

23.10

27.23

-15.17%

Interest

75.26

67.15

12.08%

Exceptional Items

0.00

Standalone Net Profit

-42.72

-41.99

-1.74%

Operating Profit Margin (Excl OI)

5.80%

4.75%

1.05%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,101.43

980.84

12.29%

Operating Profit (PBDIT) excl Other Income

152.15

146.27

4.02%

Interest

114.91

102.57

12.03%

Exceptional Items

0.00

Standalone Net Profit

23.30

30.39

-23.33%

Operating Profit Margin (Excl OI)

13.81%

14.91%

-1.10%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1,880.12

1,223.40

53.68%

Operating Profit (PBDIT) excl Other Income

297.20

188.08

58.02%

Interest

141.04

143.08

-1.43%

Exceptional Items

0.00

Standalone Net Profit

140.62

31.81

342.06%

Operating Profit Margin (Excl OI)

15.81%

15.37%

0.44%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About TruAlt Bioenergy Ltd

TruAlt Bioenergy Ltd

Small Cap

Commodity Chemicals

No Details Available.

Company Coordinates

No Company Details Available